IL6 and pulmonary arterial hypertension: And IL-6 may be involved in the proliferation of PASMCs and fibroblasts through the transcription 3 (STAT3) pathway, p38MAPK inhibitor reversed hypoxia and MCT-induced PAH (Church et al., 2015).